Neon Therapeutics, Inc. announced the appointment of Robert Bazemore to its Board of Directors. Mr. Bazemore is currently President and Chief Executive Officer of Epizyme, Inc. Mr. Bazemore has served as President and Chief Executive Officer and member of the Board of Directors of Epizyme since September 2015. Prior to joining Epizyme, Mr. Bazemore served as Chief Operating Officer of Synageva BioPharma. While at Synageva, he helped to establish the company's global commercial and medical organization to support the first product launch and helped lead the broader transition to a sustainable commercial enterprise through its acquisition in July 2015.